Research analysts at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued to clients and investors on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
CALA stock opened at $0.00 on Tuesday. Calithera Biosciences has a 12 month low of $0.00 and a 12 month high of $0.12.
About Calithera Biosciences
See Also
- Five stocks we like better than Calithera Biosciences
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- How to Invest in Small Cap Stocks
- What is a Bond Market Holiday? How to Invest and Trade
- These Are the Dividend Stocks Insiders Bought in January
- 10 Best Airline Stocks to Buy
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
